The direct-medical costs associated with interferon-based treatment for Hepatitis C in Vietnam

Background: Injectable interferon-based therapies have been used to treat hepatitis C virus (HCV) infection since 1991. International guidelines have now moved away from interferon-based therapy towards direct-acting antiviral (DAA) tablet regimens, because of their superior efficacy, excellent side...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Wellcome Open Res
Autors principals: Nguyen, Huyen Anh, Cooke, Graham S., Day, Jeremy N., Flower, Barnaby, Phuong, Le Thanh, Hung, Trinh Manh, Dung, Nguyen Thanh, Khoa, Dao Bach, Hung, Le Manh, Kestelyn, Evelyne, Thwaites, Guy E., Chau, Nguyen Van Vinh, Turner, Hugo C.
Format: Artigo
Idioma:Inglês
Publicat: F1000 Research Limited 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7372532/
https://ncbi.nlm.nih.gov/pubmed/32734002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/wellcomeopenres.15408.2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars